Risks of oral sodium phosphate for pre-colonoscopy bowel preparation in children

Surgical Endoscopy and Other Interventional Techniques

Volumn 21, Issue 6, 2007, Pages 1037-1039

  Hassall, Eric ^a   Lobe, Thom E ^b,c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Blank Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE; FLEET ENEMA; FLEETPHOSPHO SODA; LAXATIVE; MACROGOL 3350; SODIUM DIHYDROGEN PHOSPHATE; UNCLASSIFIED DRUG; X PREP;

COLONOSCOPY; DEHYDRATION; DRUG SAFETY; ELECTROLYTE DISTURBANCE; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPONATREMIA; INTESTINE PREPARATION; KIDNEY CALCIFICATION; NOTE; PEDIATRICS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; UREA NITROGEN BLOOD LEVEL;

ADMINISTRATION, ORAL; ADOLESCENT; CATHARTICS; CHILD; CHILD, PRESCHOOL; COLONOSCOPY; HUMANS; INFANT; PHOSPHATES; PREOPERATIVE CARE; WATER-ELECTROLYTE IMBALANCE;

EID: 34447309767     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-007-9398-2     Document Type: Note

References (10)

1. Wexner SD, Beck DE, Baron TH, Fanelli RD, Hyman N, Shen B, Wasco KE (2006) A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc 63:894-909. Also published in: Dis Colon Rectum 2006 49:792-809; and Surg Endosc 2006 20:1147-1160
2. Barkun A, Chiba N, Enns R, Marcon M, Natsheh S, Sadowski D, Vanner S (2006) Commonly used preparations for colonoscopy: efficacy, tolerability and safety - a Canadian Association of Gastroenterology position paper. Can J Gastroenterol 20:699-710
3. Chan A, Depew W, Vanner S (1997) Use of oral sodium phosphate colonic lavage solution by Canadian colonoscopists: pitfalls and complications. Can J Gastroenterol 11:334-338
4. Shaoul R, Wolff R, Seligman H, Tal, Jaffe M (2001) Symptoms of hyperphosphatemia, hypocalcemia, and hypomagnesemia in an adolescent after the oral administration of sodium phosphate in preparation for a colonoscopy. Gastrointest Endosc 53:650-652
5. C. B. Fleet Company (2006) Key facts about the safe use of Fleet® Phosph-soda®. Available via http://www.phosphosoda.com/professionals
6. Swann JH (2002) Important safetly information regarding Fleet® Phosph-soda® (sodium phosphates oral solution). In: Drugs & Health Products. Health Canada. http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/ prof/2002/fleet-phospho-soda_hpc-cps_e.html
7. Swann JH (2005) Reports of renal impairment and nephrocalcinosis with Fleet® Phosph-soda® (sodium phosphates oral solution). In: Drugs & Health Products. Health Canada. http://www.hc-sc.gc.ca/dhp-mps/medeff/ advisories-avis/prof/2005/phosphate_solutions_3_hpc-cps_e.html
8. Zwas FR, Cirillo NW, El-Serag HB, et al. (1996) Colonic mucosal abnormalities associated with oral sodium phosphate solution. Gastrointest Endosc 43:463-466
9. Coskun A, Uzunkoy A, Duzgun SA, et al. (2001) Experimental sodium phosphate and polyethylene glycol induce colonic tissue damage and oxidative stress. Br J Surg 88:85-89
10. Atkinson RJ, Save V, Hunter JO (2005) Colonic ulceration after sodium phosphate bowel preparation. Am J Gastroenterol 100:2603-2605